Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies
Clinical trial NCT01796470 · TERMINATED
Trial details
- NCT number
- NCT01796470
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-20
- Primary completion
- 2015-01-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.